Eli Lilly and Co
XETRA:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
XETRA:LLY
Watchlist
Price: 927.3 EUR 0.63% Market Closed
Market Cap: €881.3B

Profitability Summary

Eli Lilly and Co's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Eli Lilly and Co

Margins Comparison
Eli Lilly and Co Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
385B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.4B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
110.8B USD
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Eli Lilly and Co Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
385B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.4B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
110.8B USD
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Eli Lilly and Co

Last Value
3-Years Average
FCF Margin
Conversion Rate